Cigna Group (NYSE:CI) Announces Quarterly Earnings Results, Beats Estimates By $0.46 EPS

Cigna Group (NYSE:CI) released its earnings results on Thursday. The health services provider reported $7.98 earnings per share for the quarter, topping analysts’ consensus estimates of $7.52 by $0.46, Zacks reports. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $73.79 billion during the quarter, compared to analyst estimates of $72.64 billion. During the same quarter in the previous year, the business earned $7.83 EPS. The business’s revenue was up 5.6% on a year-over-year basis.

Here are the key takeaways from Cigna Group’s conference call:

• Positive Sentiment: Cigna reported third-quarter adjusted revenue of $73.8 billion and adjusted EPS of $7.98, and raised its 2026 adjusted EPS outlook to at least $30.60.
• Positive Sentiment: Specialty and Care Services earnings grew 15% year over year, supported by specialty pharmacy and distribution capabilities and strong adoption of lower-cost biosimilars and generics. Cigna Healthcare earnings also grew 15%, with medical costs elevated but stable and in line with pricing assumptions.
• Negative Sentiment: Evernorth Pharmacy Benefit Services faces 2027 pressure from industry-wide rebate compression and fewer employers covering GLP-1 drugs for weight loss; management expects PBS earnings to decline by a single-digit percentage. Signature adoption is expected to broaden in 2028, after the Cigna Healthcare fully insured launch in 2027.
• Positive Sentiment: Management expects at least 10% adjusted EPS growth in 2027 from an approximately $30 run-rate base, which reflects the ACA exchange exit and an estimated $200 million headwind. It also reaffirmed its long-term 10%–14% EPS growth framework and at least $45 of adjusted EPS by 2030.
• Positive Sentiment: Cigna expects its Accelerate to One modernization and productivity program to generate $3 billion in gross run-rate savings by 2030, with some savings reinvested in the business and some contributing to results.

Cigna Group Stock Performance

Shares of NYSE CI traded down $8.06 during mid-day trading on Friday, hitting $293.42. The company had a trading volume of 367,500 shares, compared to its average volume of 1,664,948. Cigna Group has a 12 month low of $255.53 and a 12 month high of $318.05. The firm has a market cap of $77.53 billion, a P/E ratio of 12.14, a PEG ratio of 1.03 and a beta of 0.25. The business’s 50-day simple moving average is $285.48 and its 200-day simple moving average is $282.05. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Thursday, December 3rd will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, December 3rd. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. Cigna Group’s dividend payout ratio is currently 25.82%.

Insider Activity

In other Cigna Group news, insider Nicole Jones sold 2,677 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the transaction, the insider owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This represents a 9.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the firm’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This represents a 10.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

More Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Adjusted earnings were $7.98 per share, ahead of analyst expectations, while revenue rose 5.6% year over year to $73.79 billion and also beat estimates. Cigna raised its 2026 adjusted earnings outlook to at least $30.60 per share. Cigna Q3 results and outlook
• Positive Sentiment: Growth in employer medical business is expected to offset Cigna’s exit from the ACA individual market, supporting the improved outlook. The company also announced a $3 billion modernization and productivity initiative and long-term targets of 10%–14% adjusted EPS growth. Cigna outlook and employer medical growth
• Positive Sentiment: Cantor Fitzgerald reaffirmed its “overweight” rating and $340 price target, while Guggenheim kept a “buy” rating despite trimming its target to $347 from $361. The continued positive ratings offer support, though Guggenheim’s cut is a more cautious signal. Analyst rating information
• Negative Sentiment: Reported net income fell to $1.4 billion, or $5.47 per share, from $1.87 billion, or $6.98 per share, a year earlier. The ACA individual-market exit is also a transition investors may weigh, even as employer medical growth is expected to offset it. Cigna reported profit and outlook

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. Barclays lifted their price objective on Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $340.00 target price on shares of Cigna Group in a report on Friday. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Cigna Group in a report on Friday, October 2nd. Evercore began coverage on Cigna Group in a research report on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 price target on the stock. Finally, Robert W. Baird set a $362.00 price target on Cigna Group in a report on Friday, July 31st. Fourteen research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $335.70.

About Cigna Group

The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.